Abiopharma

Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication

DexCom, Inc. - Dexcom Further Advances Vision of Glucose Biosensing for All

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

Virtuix Launches “Made for Meta” Omni One for Quest

Telefónica Deutschland and Blue Planet Demonstrate How AI Agents Can Accelerate 5G Network Slicing Service Design

NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone

Regions Bank Announces New Leaders in Key Markets to Drive Business Growth and Customer Experience

Dexcom Further Advances Vision of Glucose Biosensing for All

Five9 Launches Breakthrough New Release of Voice AI Agents to Power the Next Generation of Agentic Self Service

BrainChip Unveils Communication Reference Platform, Fueling Signal Intelligence at the Edge